Laura joined Osborne Clarke in 2012 and specializes in international M&A transactions as well as in corporate governance matters with respect to listed companies.
During her years of experience advising in M&A transactions, she has worked with a variety of high-profile clients, including a listed company in Spain which is one of the world leaders in plasma-based products. She also advises this client on a broad range of matters related to corporate governance.
Laura was seconded to our London office in 2014, where she worked in the corporate team and assisted in M&A transactions.
Laura has been recognised by the Iberian Lawyer as a Top 50 rising star “dolphin” in 2021. Read more here
Osborne Clarke advises Grifols on strategic USD 1 billion investment from GIC. Read more >
Osborne Clarke advises Grifols in its strategic alliance with Shanghai RAAS. Read more >
OC assists Grifols with 25 plasma centres acquisition for $370m. Read more >
Osborne Clarke assists Grifols in its strategic alliance with the Egyptian government to boost plasma-derived medicines self-sufficiency in the Middle East and Africa. Read more >
Spain modifies rules to dissolve companies and to control foreign investments
Corporate deadlock and liquidation of companies in Spain
Two recent cases examine whether, given the impossibility to liquidate a company due to a corporate deadlock, a court can...
The Draft Bill for the partial transposition of Directive 2017/828 of 17 May 2017 amending Directive 2007/36/EC with regard to the promotion of the long-term involvement of shareholders
On 25 May 2019, the Ministry of Economy and Business published on its website the Draft Bill (the "Draft Bill")...
Approval of the law on the protection of trade secrets
Law 1/2019 of 20 February 2019 on trade secrets was published in the Spanish Official State Gazette (Boletín Oficial del...